Targeting drug-resistant brain cancer using new drugs
Hossein Fallahi
July 29, 2022
New paper
Lin et al. designed TMZ analogs to overcome drug resistance in GBM. These agents generate a primary DNA lesion that can be repaired by healthy cells with intact DNA repair mechanisms. However, cancer cells that lack DNA-repair machinery are not able to repair the damage that results in selective tumor cell killing